At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety Study of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) When Administered With Other Pediatric Vaccines to Healthy Toddlers
In Brief
A Phase 3 clinical trial evaluating Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate, Measles-mumps-rubella-varicella vaccine, and 2 other interventions for Meningococcal Meningitis and 4 related conditions. Completed, enrolled 1,378 participants across 79 sites in 2 countries.
Detailed Summary
This clinical trial will evaluate the safety of two injections of Menactra® Vaccine in subjects at 9 months and at 12 months of age when the second dose is given concomitantly with other pediatric vaccines routinely administered in the US. Safety Objective: To describe the safety profile of two doses of Menactra® Vaccine.
Study Details
Timeline
Interventions
0.5 mL, IM at age 9 and 12 months
0.5 mL, intramuscular at 12 months of age
0.5 mL, Intramuscular at age 12 months
0.5 mL, Intramuscular at age 12 months